Demetrio Ortega Rumi

Summary

Country: Brazil

Publications

  1. ncbi request reprint Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study
    Demetrio Ortega Rumi
    Institute of Psychiatry, University of Sao Paulo, Faculty of Medicine, Sao Paulo SP, Brazil
    Biol Psychiatry 57:162-6. 2005
  2. ncbi request reprint Comparison of repetitive transcranial magnetic stimulation and electroconvulsive therapy in unipolar non-psychotic refractory depression: a randomized, single-blind study
    Moacyr Alexandro Rosa
    Institute of Psychiatry, University of Sao Paulo, Sao Paulo SP, Brazil
    Int J Neuropsychopharmacol 9:667-76. 2006
  3. ncbi request reprint Double-blind study to evaluate efficacy and safety of meloxicam 7.5 mg and 15 mg versus mefenamic acid 1500 mg in the treatment of primary dysmenorrhea
    Nilson Roberto de Mello
    University of Sao Paulo, São Paulo City, Brazil
    Acta Obstet Gynecol Scand 83:667-73. 2004

Collaborators

Detail Information

Publications3

  1. ncbi request reprint Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study
    Demetrio Ortega Rumi
    Institute of Psychiatry, University of Sao Paulo, Faculty of Medicine, Sao Paulo SP, Brazil
    Biol Psychiatry 57:162-6. 2005
    ..Three recent meta analyses strongly suggest its benefits in the treatment of depression. The present study investigates whether repetitive TMS (rTMS) accelerates the onset of action and increases the therapeutic effects of amitriptyline...
  2. ncbi request reprint Comparison of repetitive transcranial magnetic stimulation and electroconvulsive therapy in unipolar non-psychotic refractory depression: a randomized, single-blind study
    Moacyr Alexandro Rosa
    Institute of Psychiatry, University of Sao Paulo, Sao Paulo SP, Brazil
    Int J Neuropsychopharmacol 9:667-76. 2006
    ....
  3. ncbi request reprint Double-blind study to evaluate efficacy and safety of meloxicam 7.5 mg and 15 mg versus mefenamic acid 1500 mg in the treatment of primary dysmenorrhea
    Nilson Roberto de Mello
    University of Sao Paulo, São Paulo City, Brazil
    Acta Obstet Gynecol Scand 83:667-73. 2004
    ..5 mg and 15 mg once a day (o.a.d.) compared with mefenamic acid 500 mg three times a day (t.i.d.), over a treatment period of 3-5 days, during three menstrual cycles, for primary dysmenorrhea...